Birmingham Psychiatry Pharmaceutical — Birmingham, Alabama

Birmingham Psychiatry Pharmaceutical is a clinical research site located in Birmingham, Alabama, United States 35209.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Birmingham Psychiatry Pharmaceutical has participated in 4 clinical trials.

Therapeutic areas: Schizophrenia.

Sponsors: Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Birmingham Psychiatry Pharmaceutical?

Birmingham Psychiatry Pharmaceutical has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Birmingham Psychiatry Pharmaceutical conducted?

Birmingham Psychiatry Pharmaceutical has 4 clinical trials on record. Their work covers Schizophrenia.

Is Birmingham Psychiatry Pharmaceutical accredited by Crixeo Health?

Birmingham Psychiatry Pharmaceutical has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Birmingham Psychiatry Pharmaceutical?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.